HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 24, No 12, December 2019 – Precision Medicine for Brain Tumours       » First Alzheimer's drug to be approved in 17 years holds promise for treatment       » Tencent make medical information readily available to the public       » United States FDA approves first China-made cancer drug       » Value-Based Healthcare: A Paradigm Shift for Better Patient Outcomes       » Precision Agriculture for Future Nutritional Needs      
NEWS CRUNCH
Technology giant, Tencent Holdings Limited, promotes medical science and healthcare
Jointly organized by Tencent Medipedia and NEJM Frontier, the Chinese version of New England Journal of Medicine, the first Tencent Medical Enlightenment Summit (ME) Summit was held on the 4th of November 2019 in Beijing, China.

Technology giant, Tencent Holdings Limited, promotes medical science and healthcare

BEIJING, CHINA — 4th November 2019 // APBN Editor

The theme of the first Tencent ME summit was "Decoding Life", aimed at shedding light on the medical world and tracing mankind's evolutionary journey. In his congratulatory note for the conference, Pony Ma, Chairman of the Board and Chief Executive Officer of Tencent, said the mission of the Summit is to "encourage more people to care about life and have better self-awareness, promote public health through authoritative popular science and reduce suffering from illness."

Technology giant, Tencent Holdings Limited, promotes medical science and healthcare

In her congratulatory letter for the Summit, Tu Youyou, the first Chinese Nobel laureate in physiology or medicine, also said, "Apart from focusing on their own fields of research, medical professionals should also bear the responsibility of popularizing accurate and authoritative medical knowledge among the public. As health and wellness are critical issues to human being, the medical community and enterprises' joint attention to medical science is in line with this development trend."

At the summit, various keynote speakers highlighted important medical topics in a comprehensive manner that the general population is able to understand.

Opening the summit was Dr. Andrew Zhu Xiu Xuan Director of Liver Cancer Research, Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. Dr Zhu highlighted that 55 percent of liver cancer cases are from China, with America and Europe seeing a steady increase. He then further explains that liver cancer is preventable and has designed a series of targeted therapies that have been approved by the FDA for the treatment of liver cancer.

Drawing the attention to AIDS, was Li Taisheng, Director of the Chinese Medical Association Infectious Diseases Branch; Deputy Director of the AIDS Centre of the Chinese Academy of Medical Sciences. Director of the Department of Infectious Diseases at Peking Union Medical College Hospital and Director of the AIDS Clinic. He shared about the evolution of the AIDS program in China throughout the years and the UNAIDS goals that aims to eradicate the AIDS epidemic by the year 2030 through achieving targets of 90 percent of all people living with HIV knowing their HIV status, 90 percent of all diagnosed with HIV infection receiving sustained antiretroviral therapy, and 90 percent of those receiving antiretroviral therapy will have viral suppression.

Michael R. Philips (Fei Lipeng) then spoke about the suicide rates between various countries around the world, he is a consultant at the Department of Mental Health, World Health Organization; Associate Professor, Department of Social Medicine, Harvard University; visiting Professor, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences. Michael R. Phillips also share the 10 plans for intervention and prevention of suicides in China.

Xiao Ruiping, Chair Professor and Director of Institute of Molecular of Medicine at Peking University, Associate Editor of NEJM, Managing Editor of NEJM Frontiers in Medicine, said, "Cardiovascular disease, stroke and other chronic diseases have become the biggest health threat in China. Clinical research in China has improved significantly in recent years. We aim to introduce the most advanced international medical research and clinical practice to China, not only for the use of medical experts, but also for the benefit of general public who can access translated medical information through a reliable popular science platform." During her keynote speech she shared comparisons of global mortality rates of chronic diseases to the mortality rates in China. Some of these chronic diseases mentioned were lung cancer, stomach cancer, and liver cancer, all these making up the greatest burden on healthcare in China.

Shedding light on the use of technologies in surgery was Tibor Kovacs, President of the European Society of Surgery Oncology; Fellow of the Royal College of Surgeons; and Senior Honorary Lecturer at King's College London. He explained how the use of new technologies such as robotics, artificial intelligence, and virtual reality can help to improve surgery outcomes and better training procedures for surgeons. With the advancements in these technologies, it will help surgery be less invasive and more precise for better patient outcomes. Tibor Kovacs also cited an article from the European Journal of Surgical Oncology that there is a short learning curve for robotic surgery in nipple sparing mastectomy for breast cancer. He then ended off his speech encouraging clinicians to embrace the advancements to guide technology for better patient care.

David P. Ryan, Clinical Director of Cancer Centre in Massachusetts General Hospital; Medical Professor at Harvard Medical School, then closed the day with insights to current cancer treatments. Demonstrating the three major advancements are targeted therapy, immunotherapy, and blood-based diagnostics. He also then went on to share about the evolution of on-target resistance of cancer drugs resulting in issue then planning treatments. David P. Ryan also expressed the need for patients to understand their conditions and what is being treated on them.

This article was derived from the Tencent ME summit held on 4th November 2019, Beijing China

NEWS CRUNCH  
news Technology giant, Tencent Holdings Limited, promotes medical science and healthcare
news ECV2019 China Healthcare and Pharma Digital Innovation Summit Held Successfully in Shanghai — The "Highway" Era of Healthcare Digital Transformation
news Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health
news The Proteona Oncology Challenge using ESCAPETM Single Cell Proteogenomic Analysis
PR NEWSWIRE  
Asia Pacific Biotech News
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
October:
Disruptive Urban Farming — Microbes, Plasmids, and Recycling
November:
Evaluating cost effectiveness of genomic profiling
December:
Precision Medicine for Brain Tumours
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy